Helou, Silvia
Scynexis (United States)
2 papers on CoChat
Most cited papers
- Verified
Secukinumab in plaque psoriasis—results of two phase 3 trials
Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine
Psoriasis: Treatment and PathogenesisDermatology and Skin Diseases
Cited by 1,997
- Verified
MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis
Spec, A., Pullman, J., Thompson, G. R., Powderly, W. G., Tobin, E. H., Vazquez, J., Wring, S. A., Angulo, D., Helou, S., Pappas, P. G., et al. (2019) · Journal of Antimicrobial Chemotherapy
Antifungal resistance and susceptibilityFungal Infections and Studies
Cited by 88
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free